Amgen (AMGN) Tops Q1 EPS by 15c, Offers FY Guidance

Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.15, $0.15 better than the analyst estimate of $3.00. Revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.61 billion.

GUIDANCE:

Amgen sees FY2017 EPS of $12.00-$12.60, versus the consensus of $12.33. Amgen sees FY2017 revenue of $22.3-23.1 billion, versus the consensus of $23 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance